Log In
BCIQ
Print this Print this
 

zolpidem sublingual spray

  Manage Alerts
Collapse Summary General Information
Company ReGen Therapeutics plc
DescriptionSelective gamma-aminobutyric acid (GABA) stimulant
Molecular Target GABA receptor
Mechanism of ActionGABA receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiaschisis
Indication DetailsTreat diaschisis (neurological dormancy at sites distant from a primary site of brain damage)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today